SIRT2 and Parkinson disease: In line with a role of α-tubulin acetylation in α-synuclein aggregation, the inhibition of the tubulin deacetylase SIRT2 increases α-tubulin acetylation and reduces the formation of α-synuclein inclusion, finally alleviating PD-related neurotoxicity [55].